Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer. [electronic resource]
Producer: 20161025Description: 121-6 p. digitalISSN:- 1097-9867
- Anilides -- chemical synthesis
- Animals
- Antineoplastic Agents -- chemical synthesis
- Cell Line, Tumor
- Chemistry, Pharmaceutical -- methods
- Cyclohexanes -- chemical synthesis
- Disease Models, Animal
- Humans
- Injections, Intralesional
- Male
- Mice
- Mice, SCID
- Pharmaceutical Solutions -- chemical synthesis
- Prostatic Neoplasms, Castration-Resistant -- drug therapy
- Rats
- Treatment Outcome
- Xenograft Model Antitumor Assays -- methods
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.